IMMUNOHISTOCHEMISTRY IN THE DIFFERENTIAL-DIAGNOSIS OF NODULAR HIDRADENOMA AND GLOMUS TUMOR

被引:21
作者
HAUPT, HM
STERN, JB
BERLIN, SJ
机构
[1] NIH,BETHESDA,MD 20892
[2] DERMATOPATHOL CONSULTAT SERV,DAMASCUS,SYRIA
[3] PODIATR PATHOL LABS INC,BALTIMORE,MD
关键词
HIDRADENOMA; GLOMUS TUMOR; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE;
D O I
10.1097/00000372-199208000-00004
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The histologic distinction between nodular hidradenoma and glomus tumor is an occasional difficult diagnostic problem. Both tumors may show circumscribed aggregates of uniform epithelioid cells, a myxoid stroma, and variable numbers of blood vessels. Especially troublesome are solid cellular hidradenomas without duct-like structures and glomus tumors without a vascular pattern. To develop an immunohistochemical profile useful in this differential diagnosis, 25 selected skin tumors and four normal glomus bodies were studied with antibodies against low molecular-weight cytokeratin (CAM 5.2), epithelial membrane antigen (EMA), carcino-embryonic antigen (CEA), S-100, and vimentin (VIM). The tumors included eight unequivocal hidradenomas, seven unequivocal glomus tumors, and 10 histologically equivocal cases, originally diagnosed as glomus tumors. In all unequivocal glomus tumors and glomus bodies, only VIM was positive. Of the eight unequivocal hidradenomas, three were positive for CAM 5.2, EMA, CEA, S-100, and VIM; two for CAM 5.2 only; one for CAM 5.2, EMA, and S-100; one for CAM 5.2, EMA, and CEA; and one for CEA only. In the histologically equivocal cases, eight were positive for VIM only, characteristic of glomus tumor; and two were positive for CAM 5.2, EMA, CEA, S-100, and VIM, and were reclassified as hidradenomas. The study suggests that morphologic criteria may not always accurately differentiate between hidradenoma and glomus tumor and that in equivocal cases immunohistochemistry may be useful in the differential diagnosis.
引用
收藏
页码:310 / 314
页数:5
相关论文
共 37 条
[1]  
ACKERMAN AB, 1988, DIFFERENTIAL DIAGNOS, V2
[2]  
DISANTAGNESE PA, 1983, AM J CLIN PATHOL, V79, P130
[3]  
EGAN MJ, 1986, ARCH PATHOL LAB MED, V110, P765
[4]  
Enzinger RM., 2011, SOFT TISSUE TUMORS, P1178
[5]   AN IMMUNOHISTOLOGICAL STUDY OF BENIGN AND MALIGNANT SKIN TUMORS - EPITHELIAL ASPECTS [J].
GATTER, KC ;
PULFORD, KAF ;
VANSTAPEL, MJ ;
ROACH, B ;
MORTIMER, P ;
WOOLSTON, RE ;
TAYLORPAPADIMITRIOU, J ;
LANE, EB ;
MASON, DY .
HISTOPATHOLOGY, 1984, 8 (02) :209-227
[6]  
GOWN AM, 1984, ADV IMMUNOHISTOCHEMI
[7]  
HAIMOTO H, 1987, LAB INVEST, V57, P489
[8]   ULTRASTRUCTURE OF A GLOMUS TUMOUR [J].
HARRIS, M .
JOURNAL OF CLINICAL PATHOLOGY, 1971, 24 (06) :520-&
[9]   CLEAR CELL HIDRADENOMA - HISTOLOGICAL HISTOCHEMICAL AND ELECTRON MICROSCOPIC STUDIES [J].
HASHIMOTO, K ;
DIBELLA, RJ ;
LEVER, WF .
ARCHIVES OF DERMATOLOGY, 1967, 96 (01) :18-+
[10]   MIXED TUMORS OF THE SKIN - A HISTOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY [J].
HASSABELNABY, HM ;
TAM, S ;
WHITE, WL ;
ACKERMAN, AB .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1989, 11 (05) :413-428